CONDENSED CONSOLIDATED STOCKHOLDERS' EQUITY STATEMENTS (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Convertible Preferred Stock [Member]	Total	Cumulative Effect, Period of Adoption, Adjustment [Member] Accumulated Deficit [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]
Balance at Dec. 31, 2018	$ 6,662,351	$ 7,348,390	$ (25,734,088)	$ 20,150,116	$ 8,426,769
Balance (ASU 2016-02 [Member]) at Dec. 31, 2018						$ (103,015)	$ (103,015)
Balance (in shares) at Dec. 31, 2018	66,623,514,522			20,150
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with cashless exercise of Series A warrants	$ 2,175	(1,274)			901
Issuance of common stock in connection with cashless exercise of Series A warrants (in shares)	21,743,172
Stock-based compensation expense		196,254			196,254
Net loss			(2,016,843)		(2,016,843)
Balance at Jun. 30, 2019	$ 6,664,526	7,543,370	(27,853,946)	$ 20,150,116	6,504,066
Balance (in shares) at Jun. 30, 2019	66,645,257,694			20,150
Balance at Mar. 31, 2019	$ 6,663,438	7,460,832	(26,949,632)	$ 20,150,116	7,324,754
Balance (in shares) at Mar. 31, 2019	66,634,387,066			20,150
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with cashless exercise of Series A warrants	$ 1,088	(637)			451
Issuance of common stock in connection with cashless exercise of Series A warrants (in shares)	10,870,628
Stock-based compensation expense		83,175			83,175
Net loss			(904,314)		(904,314)
Balance at Jun. 30, 2019	$ 6,664,526	7,543,370	(27,853,946)	$ 20,150,116	6,504,066
Balance (in shares) at Jun. 30, 2019	66,645,257,694			20,150
Balance at Dec. 31, 2019	$ 6,769,849	7,618,245	(28,636,479)	$ 20,150,116	5,901,731
Balance (in shares) at Dec. 31, 2019	67,698,494,244			20,150
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with cashless exercise of Series A warrants	$ 1,985,980	(1,985,980)			$ 0
Issuance of common stock in connection with cashless exercise of Series A warrants (in shares)	19,859,802,354				19,859,802,354
Stock-based compensation expense		74,279			$ 74,279
Net loss			(1,509,974)		(1,509,974)
Balance at Jun. 30, 2020	$ 8,755,829	5,706,544	(30,146,453)	$ 20,150,116	4,466,036
Balance (in shares) at Jun. 30, 2020	87,558,296,598			20,150
Balance at Mar. 31, 2020	$ 7,249,743	7,220,295	(29,327,773)	$ 20,150,116	5,292,381
Balance (in shares) at Mar. 31, 2020	72,497,427,011			20,150
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with cashless exercise of Series A warrants	$ 1,506,086	(1,506,086)			0
Issuance of common stock in connection with cashless exercise of Series A warrants (in shares)	15,060,869,587
Stock-based compensation expense		(7,665)			(7,665)
Net loss			(818,680)		(818,680)
Balance at Jun. 30, 2020	$ 8,755,829	$ 5,706,544	$ (30,146,453)	$ 20,150,116	$ 4,466,036
Balance (in shares) at Jun. 30, 2020	87,558,296,598			20,150